For example, Patel et al. reported that the BRAF inhibitor encorafenib and the MEK inhibitor binimetinib, when combined with stereotactic radiosurgery, improved local control of melanoma brain metastases without significant toxicity 36. This evidence concerns the gene MAP2K7 and melanoma.